Lucy Di Marco

Lucy Di Marco

Auto-generated profile, based on publicly available information

Lucy Di Marco

Radiologie neuro-ORL et ostéo-articulaire, hôpital Edouard-Herriot, pavillon B, 5, place d'Arsonval, 69437 Lyon cedex 03, France

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2017 in Abdominal Radiology
Verified
Journal Article
Closed access
PDF file
GAGilles Abdulmalak
Gilles Abdulmalak
OCOlivier CHEVALLIER
Olivier CHEVALLIER
NFNicolas Falvo
Nicolas Falvo
LMLucy Di Marco
Lucy Di Marco
ABAurelie Bertaut
Aurelie Bertaut
RLRomaric Loffroy
Romaric Loffroy

1 February 2017 in Quantitative Imaging in Medicine and Surgery
Verified
Journal Article
Closed access
PDF file
FBFlorian Bardin
Florian Bardin
OCOlivier CHEVALLIER
Olivier CHEVALLIER
ABAurelie Bertaut
Aurelie Bertaut
EDEmmanuel Delorme
Emmanuel Delorme
MMMorgan Moulin
Morgan Moulin
RLRomaric Loffroy
Romaric Loffroy
Background: Angiomyolipoma (AML) is the most common renal benign tumor. Treatment should be considered for symptomatic patients or for those at risk for complications, especially retroperitoneal bleeding which is correlated to tumor size, grade of the angiogenic component and to the presence of tuberous sclerosis complex (TSC). This study reports our single-center experience with the use of selective arterial embolization (SAE) in the management of symptomatic and asymptomatic renal AMLs. Methods: In this retrospective mono-centric study, all demographic and imaging data, medical records, angiographic features, outpatient charts and follow-up visits of patients who underwent prophylactic or emergency SAE for AMLs between January 2005 and July 2016 were reviewed. Tumor size and treatment outcomes were assessed at baseline and after the procedure during follow-up. Computed tomography (CT), magnetic resonance imaging (MRI) or ultrasonography was used to evaluate AML shrinkage. Renal function was measured pre- and post-procedure. Results: Twenty-three patients (18 females, 5 males; median age, 45 years; range, 19–85 years) who underwent SAE either to treat bleeding AML (n=6) or as a prophylactic treatment (n=17) were included. Overall, 34 AMLs were embolized. TSC status was confirmed for 6 patients. Immediate technical success rate was 96% and 4 patients benefitted from an additional procedure. Major complications occurred in 3 patients and minor post-embolization syndrome (PES) in 14 patients. The mean AML size reduction rate was 26.2% after a mean follow-up was 20.5 months (range, 0.5–56 months), and only non-TSC status was significantly associated with better shrinkage of tumor (P=0.022). Intralesional aneurysms were significantly more frequent in patients with hemorrhagic presentation (P=0.008). There was no change in mean creatinine level after SAE. Conclusions: SAE is a safe and effective technique to manage renal AMLs as a preventive treatment as well as in emergency setting, with significant reduction in tumor size during follow-up. A multidisciplinary approach remains fundamental, especially for TSC patients. In addition to size, the presence of intralesional aneurysms should be considered in any prophylactic treatment decision.

1 July 2016 in Diagnostic and Interventional Imaging
Verified
Journal Article
Closed access
JPJean Baptiste Pialat
Jean Baptiste Pialat
LML. Di Marco
L. Di Marco
AFA. Feydy
A. Feydy
CPC. Peyron
C. Peyron
BPB. Porta
B. Porta
SAS. Aubry
S. Aubry

8 January 2016 in Insights into Imaging
Verified
Journal Article
Open access
PDF file
LMLucy Di Marco
Lucy Di Marco
MAMichael Bret Anderson
Michael Bret Anderson
The American Board of Medical Specialties (ABMS) has approved a “new” residency: dual Certification in Interventional Radiology (IR) / Diagnostic Radiology (DR). This IR/DR program intends to better prepare future IR doctors. Residency programs can apply for the IR/DR program beginning in 2015, with full nationwide implementation of the IR/DR residency likely to ramp up by 2022. The IR/DR dual certificate can be attained via an “Integrated” or “Independent” IR/DR residency pathway. The IR/DR training pathway may lead the way to the future training of IR/DR physicians worldwide. Certainly, the ABMS approval of a “new” residency is rare and worth attention; however, as with all things new, questions and concerns will be raised. • The ABMS approved a “new” residency, the IR/DR dual Certification. • This IR/DR program intends to better prepare future IR doctors. • Full nationwide implementation of the IR/DR Residency is likely by 2022. • The IR/DR certificate can be attained via the Integrated or the Independent residency pathway. • These programs may lead the way to the future training of IR/DR physicians worldwide.

26 June 2017 in Journal of Magnetic Resonance Imaging
Verified
Journal Article
Closed access
PDF file
ANAngeline Nemeth
Angeline Nemeth
LMLucy Di Marco
Lucy Di Marco
FBFlorent Boutitie
Florent Boutitie
MSMichael Sdika
Michael Sdika
DGDenis Grenier
Denis Grenier
JPJean‐Baptiste Pialat
Jean‐Baptiste Pialat

1 November 2017 in Diagnostic and Interventional Imaging
Verified
Journal Article
Closed access
NPN. Pyatigorskaya
N. Pyatigorskaya
LML. Di Marco
L. Di Marco